UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis

Human molecular genetics, 2017-09, Vol.26 (18), p.3564-3572

2017

Volltextzugriff (PDF)

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease

Movement disorders, 2016-03, Vol.31 (3), p.335-343

2016

Volltextzugriff (PDF)

Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models

ACS chemical neuroscience, 2021-03, Vol.12 (5), p.893-905

2021

Volltextzugriff (PDF)

Differential micro RNA expression in PBMC from multiple sclerosis patients

PloS one, 2009-07, Vol.4 (7), p.e6309-e6309

2009

Volltextzugriff (PDF)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

Journal of neuroinflammation, 2022-11, Vol.19 (1), p.1-277, Article 277

2022

Volltextzugriff (PDF)

Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

Frontiers in immunology, 2022-10, Vol.13, p.960761-960761

2022

Volltextzugriff (PDF)

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

International journal of molecular sciences, 2018-08, Vol.19 (8), p.2448

2018

Volltextzugriff (PDF)

Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study

Frontiers in immunology, 2021-03, Vol.12, p.614715-614715

2021

Volltextzugriff (PDF)

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

European journal of neurology, 2023-04, Vol.30 (4), p.1014-1024

2023

Volltextzugriff (PDF)

Age gene expression and coexpression progressive signatures in peripheral blood leukocytes

Experimental gerontology, 2015-12, Vol.72, p.50-56

2015

Volltextzugriff (PDF)

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

European journal of neurology, 2022-08, Vol.29 (8), p.2321-2334

2022

Volltextzugriff (PDF)

Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls

Biomedicines, 2021-12, Vol.9 (12), p.1850

2021

Volltextzugriff (PDF)

Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

PloS one, 2014-02, Vol.9 (2), p.e90482-e90482

2014

Volltextzugriff (PDF)

Bacteria-Fungi Interactions in Multiple Sclerosis

Microorganisms (Basel), 2024-05, Vol.12 (5), p.872

2024

Volltextzugriff (PDF)

Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease

Biomedicines, 2020-11, Vol.8 (12), p.540

2020

Volltextzugriff (PDF)

Smoking and multiple sclerosis

Revista de neurologiá, 2015-02, Vol.60 (4), p.169-178

2015

Volltextzugriff (PDF)

RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers

Human molecular genetics, 2020-12, Vol.29 (20), p.3361-3372

2020

Volltextzugriff (PDF)

Tabaco y esclerosis múltiple

Revista de neurologiá, 2015, Vol.60 (4), p.169

2015

Volltextzugriff (PDF)

Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review

PloS one, 2013-07, Vol.8 (7), p.e66308-e66308

2013

Volltextzugriff (PDF)

Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa

Revista de neurologiá, 2014-04, Vol.58 (8), p.337-344

2014

Volltextzugriff (PDF)

Fingolimod: efectividad y seguridad en la práctica clínica habitual. Estudio observacional, retrospectivo y multicéntrico en Navarra, Gipuzkoa y La Rioja

Revista de neurologiá, 2016, Vol.63 (S01), p.5

2016

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Englisch
(75)
Spanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(54)
Multiple Sclerosis
(45)
Neurosciences & Neurology
(39)
Clinical Neurology
(36)
Humans
(31)
Female
(21)
Adult
(20)
Middle Aged
(18)
Neurosciences
(17)
Male
(15)
Patients
(14)
Biomarkers
(10)
Immunology
(9)
Gene Expression
(8)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(8)
Neurology
(8)
Aged
(7)
Biochemistry & Molecular Biology
(7)
Recurrence
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease

Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models

Differential micro RNA expression in PBMC from multiple sclerosis patients

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

Age gene expression and coexpression progressive signatures in peripheral blood leukocytes

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls

Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

Bacteria-Fungi Interactions in Multiple Sclerosis

XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)

XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)

Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease

Smoking and multiple sclerosis

RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers

Tabaco y esclerosis múltiple

Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa

Fingolimod: efectividad y seguridad en la práctica clínica habitual. Estudio observacional, retrospectivo y multicéntrico en Navarra, Gipuzkoa y La Rioja

Household paired design reduces variance and increases power in multi-city gut microbiome study in multiple sclerosis

Suchergebnisse filtern